Showing results (231-240 of 246) with videos related to
Sort By:
Pageof 25
Oncotarget|January 10, 2018
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cellsNicola Mitwasi, Anja Feldmann, Ralf Bergmann, et al.Journal of Medicinal Chemistry|April 18, 2018
Nε-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic ProfilingRobert Wodtke, Christoph Hauser, Gloria Ruiz-Gómez, et al.Small (Weinheim an Der Bergstrasse, Germany)|February 8, 2022
A Self-Assembled Matrix System for Cell-Bioengineering Applications in Different Dimensions, Scales, and GeometriesYong Xu, Michelle Patino Gaillez, Kai Zheng, et al.Journal of Autoimmunity|March 6, 2018
Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technologyStefanie Koristka, Alexandra Kegler, Ralf Bergmann, et al.Scientific Reports|February 17, 2017
Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapyRoberta Aliperta, Petra B Welzel, Ralf Bergmann, et al.Journal of Medicinal Chemistry|October 13, 2025
"Precision on Two Wheels"─Structural Refinement of 64Cu- and 68Ga-Labeled Bicyclic Peptides Targeting Nectin-4 for Improved Tumor Imaging: From Preclinical Development to First-in-Human ApplicationTobias Krönke, Johanna Trommer, Martin Ullrich, et al.Oncoimmunology|May 17, 2017
A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platformSusann Albert, Claudia Arndt, Anja Feldmann, et al.Oncotarget|February 28, 2018
Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cellsDominik Bachmann, Roberta Aliperta, Ralf Bergmann, et al.Advanced Materials (Deerfield Beach, Fla.)|June 17, 2026
Soft, Degradable, and Magnetic Microcarriers for Encapsulation and Guided Transport of Drugs and 3D SpheroidsXuan Peng, Lulu Song, Daryna Mruga, et al.Frontiers in Immunology|May 1, 2023
Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cellsHaidy A Saleh, Nicola Mitwasi, Martin Ullrich, et al.Pageof 25